PT-141 20mg

Description

Overview A cyclic heptapeptide melanocortin receptor agonist supplied as lyophilized powder in sealed vial format at 20mg. Also available as PT-141 Nasal Spray 20mg for laboratories working in a nasal presentation. Supplied for controlled in vitro work by qualified laboratory personnel.

Research Background & Mechanistic Focus PT-141 is a metabolite-derived analogue of alpha-melanocyte stimulating hormone, studied for its activity across the melanocortin receptor family with particular attention on MC3R and MC4R subtype selectivity. Because the melanocortin system spans five known receptor subtypes with distinct tissue distributions, selectivity profiling is the dominant research question. Common laboratory contexts include competitive radioligand binding against each receptor subtype, cAMP accumulation assays in receptor-transfected lines, and structure activity comparison against the parent hormone sequence. Its cyclic structure confers greater stability than linear melanocortin analogues.

Structural Information Classification: Melanocortin analog peptide Form: Lyophilized vial presentation Catalog Strengths: 20mg

Research Applications Used in controlled laboratory settings for receptor-signaling models, comparative pathway analysis, presentation or stability work where applicable, and other non-clinical analytical workflows consistent with authorized research use.

Specifications Research-grade material supplied in lyophilized vial presentation at 20mg. Intended for controlled laboratory handling and analytical preparation only.

Handling & Use Conditions Allow the vial to equilibrate before opening. Reconstitute only under controlled laboratory conditions using appropriate technique. Avoid vigorous agitation, repeated freeze-thaw exposure, and unnecessary environmental exposure during handling.

Storage & Stability Store refrigerated or frozen according to laboratory protocol, protected from light and repeated freeze-thaw cycling. Reconstituted material should be stored only under controlled conditions appropriate for short-term analytical use.

Sourcing Statement RawBiotix research compounds are sourced through U.S.-based supply and verified through independent analytical testing. Minimum 98% purity. Certificates of Analysis available upon request.

Disclaimer For laboratory research use only. Not for human consumption, therapeutic, or diagnostic purposes.